Gene · 799
Papers3,617
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 3,617
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubrogepant: Mechanism of action, clinical and translational science. | Clin Transl Sci | 2024 | 38266060 | PubTator, text mining | PubMed |
| Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity. | Bone Res | 2024 | 38263167 | PubTator, text mining | PubMed |
| A Two-Step Mechanism for Creating Stable, Condensed Chromatin with the Polycomb Complex PRC1. | Molecules | 2024 | 38257239 | PubTator, text mining | PubMed |
| Exposure to Secondhand Smoke Extract Increases Cisplatin Resistance in Head and Neck Cancer Cells. | Int J Mol Sci | 2024 | 38256106 | PubTator, text mining | PubMed |
| Combined 6-benzylaminopurine and H2O2 stimulate the astaxanthin biosynthesis in Xanthophyllomyces dendrorhous. | Appl Microbiol Biotechnol | 2024 | 38252271 | PubTator, text mining | PubMed |
| Immunoregulatory function of SP-A. | Mol Immunol | 2024 | 38244369 | PubTator, text mining | PubMed |
| Molecular Mechanism of SLC6A8 Dysfunction with c.1699T > C (p.S567P) Mutation in Cerebral Creatine Deficiency Syndromes. | Biol Pharm Bull | 2024 | 38233148 | PubTator, text mining | PubMed |
| Plant-derived natural medicines for the management of osteoporosis: A comprehensive review of clinical trials. | J Tradit Complement Med | 2024 | 38223808 | PubTator, text mining | PubMed |
| Osteoporosis therapy using nanoparticles: a review. | Ann Med Surg (Lond) | 2024 | 38222677 | PubTator, text mining | PubMed |
| Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson's disease model. | Nat Commun | 2024 | 38200091 | PubTator, text mining | PubMed |
| A framework for Frizzled-G protein coupling and implications to the PCP signaling pathways. | Cell Discov | 2024 | 38182578 | PubTator, text mining | PubMed |
| Quantitative association between lead exposure and amyotrophic lateral sclerosis: a Bayesian network-based predictive study. | Environ Health | 2024 | 38166850 | PubTator, text mining | PubMed |
| ABCB1 overexpression through locus amplification represents an actionable target to combat paclitaxel resistance in pancreatic cancer cells. | J Exp Clin Cancer Res | 2024 | 38163893 | PubTator, text mining | PubMed |
| Generation of highly pure pluripotent stem cell-derived myogenic progenitor cells and myotubes. | Stem Cell Reports | 2024 | 38101399 | PubTator, text mining | PubMed |
| GproteinDb in 2024: new G protein-GPCR couplings, AlphaFold2-multimer models and interface interactions. | Nucleic Acids Res | 2024 | 38000391 | PubTator, text mining | PubMed |
| A surge of cytosolic calcium dysregulates lysosomal function and impairs autophagy flux during cupric chloride-induced neuronal death. | J Biol Chem | 2024 | 37981210 | PubTator, text mining | PubMed |
| New strategies for evaluating imidacloprid-induced biological consequences targeted to Eisenia fetida species and the corresponding mechanisms of its toxicity. | J Environ Manage | 2024 | 37897899 | PubTator, text mining | PubMed |
| Predictors of Response Following Neoadjuvant Cisplatin-Based Chemotherapy for Muscle Invasive Urothelial Bladder Cancer Using Molecular Profile: A Prospective Clinical Study. | Clin Genitourin Cancer | 2024 | 37758560 | PubTator, text mining | PubMed |
| Role of PLC/IP3 /IP3 R axis in excess molybdenum exposure induced apoptosis in duck renal tubular epithelial cells. | Environ Toxicol | 2024 | 37676969 | PubTator, text mining | PubMed |
| Pharmacological characterisation of erenumab, Aimovig, at two calcitonin gene-related peptide responsive receptors. | Br J Pharmacol | 2024 | 37580864 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/799/papers?page=15